Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2021-01-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
关于实际控制人部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the release of pledged shares by its actual controller. It details the number of shares released from pledge, the shareholders involved, and the pledgee institutions. The document is short (1818 characters) and focuses on share pledge status changes, not on financial results, management changes, or other report types. It is an announcement about share pledge status, which fits best under the category of Regulatory Filings (RNS) as it is a regulatory disclosure about share pledge changes and does not fit other more specific categories like Share Issue/Capital Change or Transaction in Own Shares, since it is about pledge release, not share issuance or buyback. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2021-01-19 Chinese
关于实际控制人持股变动的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a change in shareholding by the actual controller of the company, detailing the transfer of shares between parties and the resulting shareholding percentages. It references regulatory compliance and confirms no change in actual control or governance structure. There is no financial report, earnings data, or management discussion. The document is a formal announcement of a change in major shareholding, fitting the category of Major Shareholding Notification.
2021-01-19 Chinese
关于股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Jiangsu Sihuan Bio Co., Ltd. regarding abnormal stock price fluctuations over a few trading days. It includes statements about the company's verification of information, confirmation of no undisclosed material information, and risk warnings to investors. The document does not contain financial statements, audit results, or detailed financial data. It is a regulatory disclosure related to stock price movements and compliance with stock exchange rules, typical of a regulatory filing. The document length is short (1186 characters), and it is not a report or presentation but an announcement about stock trading behavior and company statements. Therefore, it fits best under Regulatory Filings (RNS).
2021-01-13 Chinese
2020年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2020 Third Quarter Report" of 江苏四环生物股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and management commentary on financial performance for the third quarter of 2020. The length of the document (15,000 characters) and the presence of comprehensive financial statements and analysis confirm it is a substantive financial report rather than a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2020
2020-10-29 Chinese
2020年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled '江苏四环生物股份有限公司 2020 年第三季度报告正文', which translates to 'Jiangsu Sihuan Biological Co., Ltd. 2020 Third Quarter Report'. It contains detailed financial data and analysis for the third quarter of 2020, including key financial metrics, cash flow statements, shareholder information, and management commentary on financial performance and changes. The presence of comprehensive financial statements and substantive financial data for a period shorter than a full fiscal year clearly indicates this is an Interim / Quarterly Report. The document length (6998 characters) and content confirm it is the full report, not just an announcement or summary. Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). 9M 2020
2020-10-29 Chinese
关于实际控制人部分股份解除质押及再质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the release and re-pledging of shares by the actual controller of the company, including detailed information about share pledges, shareholder names, pledge amounts, and related financial data of the controlling entity. It does not contain financial statements, earnings data, or management discussion of financial results. It is a regulatory announcement about share pledging activities by a major shareholder, which fits the category of Major Shareholding Notification (MRQ). The document length is about 4200 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the appropriate classification is MRQ.
2020-10-20 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.